BioCryst Pharmaceuticals
BCRX
#4785
Rank
S$2.08 B
Marketcap
$10.08
Share price
2.60%
Change (1 day)
39.58%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$1.29 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are S$1.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$1.28 B13.43%
2022-12-31S$1.13 B20.48%
2021-12-31S$0.93 B100.68%
2020-12-31S$0.46 B153.48%
2019-12-31S$0.18 B38.54%
2018-12-31S$0.13 B5.51%
2017-12-31S$0.12 B-1.07%
2016-12-31S$0.12 B21.01%
2015-12-31S$0.10 B30.47%
2014-12-31S$80.91 M27.75%
2013-12-31S$63.33 M-10.53%
2012-12-31S$70.79 M-18.89%
2011-12-31S$87.28 M54.21%
2010-12-31S$56.6 M-27.9%
2009-12-31S$78.51 M43.47%
2008-12-31S$54.72 M-51.13%
2007-12-31S$0.11 B54.28%
2006-12-31S$72.57 M6.82%
2005-12-31S$67.94 M1228.77%
2004-12-31S$5.11 M82.58%
2003-12-31S$2.8 M37.72%
2002-12-31S$2.03 M-51.87%
2001-12-31S$4.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.17 B-8.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.20 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.82 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.02 B 134.46%๐Ÿ‡บ๐Ÿ‡ธ USA
S$47.62 B 3,586.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$50.17 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$80.33 B 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$1.51 B 17.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.99 M-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA